2018 - The Pharmacare Group, represented by our Malta Pharmacare Premium (PCM) partner, has recently signed a co-development agreement with the Gena-Pharm Greek pharmaceutical company to manufacture three oncology generics. Two products have been in progress so far and a third is presently in consideration. The two have so far had their pilots and prototypes finalised and would be undergoing clinical trials anticipated to conclude towards the end of the year.